Ameriprise’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAT
PCM
Ameriprise's BCAT Position: Q2 2026 in Review
Ameriprise increased its BlackRock Capital Allocation Term Trust (BCAT) stake by 382% in Q2 2026, buying an estimated $7.07M and bringing the position to 580,806 shares worth $9.26M. The position accounts for ﹤0.01% of the portfolio, ranked #2109.
Ameriprise first reported a position in BCAT in Q2 2021 and has held it in 21 quarters since. 110 funds tracked by Wall St. Rank hold BCAT as of Q2 2026.
- Ameriprise held 580,806 shares of BlackRock Capital Allocation Term Trust worth $9.26M as of Q2 2026.
- Ameriprise bought 460,346 BlackRock Capital Allocation Term Trust shares in Q2 2026, an estimated $7.07M.
- BlackRock Capital Allocation Term Trust made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #2109 holding.
- Ameriprise first reported a position in BlackRock Capital Allocation Term Trust in Q2 2021 and has held it in 21 quarters since.
- 110 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q2 2026.
Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.